Paper31419329
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.
Sauvet F and 18 others. Br J Clin Pharmacol, 2019. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target. Papers, record 31419329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31419329
- Disease
- narcolepsy17 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.
- PubMed
- Publication types
- Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Flecainide | Major topic |
| Modafinil | Major topic |
| Neuroglia | Major topic |
| Sleep Deprivation | Major topic |
| Wakefulness-Promoting Agents | Major topic |
| Adult | |
| Arousal | |
| Cognition | |
| Connexins | |
| Cross-Over Studies | |
| Drug Combinations | |
| Healthy Volunteers | |
| Humans | |
| Male | |
| Memory, Short-Term | |
| Psychomotor Performance | |
| Reaction Time | |
| Treatment Outcome | |
| Wakefulness | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03182413 | Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation | Derived from the trial | Yes |
Source ClinicalTrials.gov
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22558075 | Executive control of attention in narcolepsy. | PLoS One | 2012 | https://conductscience.org/library/papers/22558075 | PubMed |
| 2 | 19238808 | Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. | Sleep | 2009 | https://conductscience.org/library/papers/19238808 | PubMed |
| 3 | 27155860 | Treatment Options for Narcolepsy. | CNS Drugs | 2016 | https://conductscience.org/library/papers/27155860 | PubMed |
| 4 | 2305168 | Tests of memory in narcoleptics. | Sleep | 1990 | https://conductscience.org/library/papers/2305168 | PubMed |
| 5 | 28694772 | Connexin-Dependent Neuroglial Networking as a New Therapeutic Target. | Front Cell Neurosci | 2017 | https://conductscience.org/library/papers/28694772 | PubMed |
| 6 | 1798888 | A new method for measuring daytime sleepiness: the Epworth sleepiness scale. | Sleep | 1991 | https://conductscience.org/library/papers/1798888 | PubMed |
| 7 | 19812711 | Assessing inattention and impulsivity in children during the Go/NoGo task. | Br J Dev Psychol | 2009 | https://conductscience.org/library/papers/19812711 | PubMed |
| 8 | 3720173 | Pharmacodynamics and side effects of flecainide acetate. | Clin Pharmacol Ther | 1986 | https://conductscience.org/library/papers/3720173 | PubMed |
| 9 | 23709163 | PC-PVT: a platform for psychomotor vigilance task testing, analysis, and prediction. | Behav Res Methods | 2014 | https://conductscience.org/library/papers/23709163 | PubMed |
| 10 | 7557823 | Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. | Fundam Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7557823 | PubMed |
| 11 | 29635319 | Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination. | Int J Neuropsychopharmacol | 2018 | https://conductscience.org/library/papers/29635319 | PubMed |
| 12 | 17993041 | Evaluation of the safety of modafinil for treatment of excessive sleepiness. | J Clin Sleep Med | 2007 | https://conductscience.org/library/papers/17993041 | PubMed |
| 13 | 16120100 | Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. | J Sleep Res | 2005 | https://conductscience.org/library/papers/16120100 | PubMed |
| 14 | 21737301 | Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-α) levels in healthy men. | Cytokine | 2011 | https://conductscience.org/library/papers/21737301 | PubMed |
| 15 | 21532951 | Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. | Sleep | 2011 | https://conductscience.org/library/papers/21532951 | PubMed |
| 16 | 9038284 | A parametric study of prefrontal cortex involvement in human working memory. | Neuroimage | 1997 | https://conductscience.org/library/papers/9038284 | PubMed |
| 17 | 28774856 | Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. | Neuropharmacology | 2017 | https://conductscience.org/library/papers/28774856 | PubMed |
| 18 | 23665355 | The psychostimulant modafinil enhances gap junctional communication in cortical astrocytes. | Neuropharmacology | 2013 | https://conductscience.org/library/papers/23665355 | PubMed |
| 19 | 22786894 | Human connexin channel specificity of classical and new gap junction inhibitors. | J Biomol Screen | 2012 | https://conductscience.org/library/papers/22786894 | PubMed |
| 20 | 25394226 | Current and future directions in clinical fatigue management: An update for emergency medicine practitioners. | Emerg Med Australas | 2014 | https://conductscience.org/library/papers/25394226 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42040193 | Short sleep recovery partially restores decision-making alterations induced by total sleep deprivation. | Sleep Adv | 2026 | https://conductscience.org/library/papers/42040193 | PubMed |
| 40829856 | Human augmentation to deliver an enhanced and resilient people capability for Defence. | BMJ Mil Health | 2025 | https://conductscience.org/library/papers/40829856 | PubMed |
| 37760916 | Exploring Astrocyte-Mediated Mechanisms in Sleep Disorders and Comorbidity. | Biomedicines | 2023 | https://conductscience.org/library/papers/37760916 | PubMed |
| 35550156 | Translational approaches to influence sleep and arousal. | Brain Res Bull | 2022 | https://conductscience.org/library/papers/35550156 | PubMed |
| 35321359 | Effects of Caffeine Intake on Cognitive Performance Related to Total Sleep Deprivation and Time on Task: A Randomized Cross-Over Double-Blind Study. | Nat Sci Sleep | 2022 | https://conductscience.org/library/papers/35321359 | PubMed |
| 35163606 | Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163606 | PubMed |
| 32903470 | Pharmaco-fUS for Characterizing Drugs for Alzheimer's Disease - The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine. | Front Neurosci | 2020 | https://conductscience.org/library/papers/32903470 | PubMed |
| 32612499 | Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer's Disease. | Front Neurosci | 2020 | https://conductscience.org/library/papers/32612499 | PubMed |
| 31419329 | Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31419329 | PubMed |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| MODAFINIL | CHEMBL1373 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1373 | ChEMBL |
| FLECAINIDE | CHEMBL652 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL652 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31419329
GET https://conductscience.org/api/papers/v1/31419329/references?page=2